APA (7th ed.) Citation

KR, S., MS, C., R, D., M, S., A, Y., KE, D., . . . E, K. (2026). Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026) Part I: Evaluation and Treatment of Biochemically Recurrent (Following Exhaustion of Local Therapy) and Metastatic Hormone-Sensitive Prostate Cancer. The Journal of urology, 101097JU0000000000005220. https://doi.org/10.1097/JU.0000000000005220

Chicago Style (17th ed.) Citation

KR, Scarpato, Cookson MS, Dreicer R, Sayan M, Yu A, D'Anci KE, Pak LJ, and Kirkby E. "Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026) Part I: Evaluation and Treatment of Biochemically Recurrent (Following Exhaustion of Local Therapy) and Metastatic Hormone-Sensitive Prostate Cancer." The Journal of Urology 2026: 101097JU0000000000005220. https://doi.org/10.1097/JU.0000000000005220.

MLA (9th ed.) Citation

KR, Scarpato, et al. "Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026) Part I: Evaluation and Treatment of Biochemically Recurrent (Following Exhaustion of Local Therapy) and Metastatic Hormone-Sensitive Prostate Cancer." The Journal of Urology, 2026, p. 101097JU0000000000005220, https://doi.org/10.1097/JU.0000000000005220.